Cite
Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.
MLA
Zaman, Saif, et al. “Combinatorial Therapy of Zinc Metallochaperones with Mutant P53 Reactivation and Diminished Copper Binding.” Molecular Cancer Therapeutics, vol. 18, no. 8, Aug. 2019, pp. 1355–65. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-18-1080.
APA
Zaman, S., Yu, X., Bencivenga, A. F., Blanden, A. R., Liu, Y., Withers, T., Na, B., Blayney, A. J., Gilleran, J., Boothman, D. A., Loh, S. N., Kimball, S. D., & Carpizo, D. R. (2019). Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding. Molecular Cancer Therapeutics, 18(8), 1355–1365. https://doi.org/10.1158/1535-7163.MCT-18-1080
Chicago
Zaman, Saif, Xin Yu, Anthony F Bencivenga, Adam R Blanden, Yue Liu, Tracy Withers, Bing Na, et al. 2019. “Combinatorial Therapy of Zinc Metallochaperones with Mutant P53 Reactivation and Diminished Copper Binding.” Molecular Cancer Therapeutics 18 (8): 1355–65. doi:10.1158/1535-7163.MCT-18-1080.